首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Pindolol-insensitive 3H-5-hydroxytryptamine binding in the rat hypothalamus; identity with 5-hydroxytryptamine7 receptors
【2h】

Pindolol-insensitive 3H-5-hydroxytryptamine binding in the rat hypothalamus; identity with 5-hydroxytryptamine7 receptors

机译:在大鼠下丘脑中对品多洛尔不敏感的3H -5-羟基色胺结合;与5-羟色胺7受体的同一性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="enumerated" style="list-style-type:decimal">Pindolol-insensitive [3H]-5-hydroxytryptamine ([3H]-5-HT) binding to rat hypothalamic membranes was pharmacologically and functionally characterized to resolve whether this procedure selectively labels 5-HT7 receptors.Consistent with a previous report, 3 μM and not 100 nM pindolol was required to occupy fully 5-HT1A and 5-HT1B receptors. Remaining [3H]-5-HT binding was saturable (KD, 1.59±0.21 nM; Bmax, 53.8±3.1 fmol.mg protein−1).Displacement of [3H]-5-HT with metergoline and 5-CT revealed shallow Hill slopes (<0.5) but seven other compounds had slopes >0.8 and pKi values and the rank order of affinity were significantly correlated (r=0.81 and 0.93, respectively) with published [3H]-5-HT binding to rat recombinant 5-HT7 receptors.In the presence of pindolol, 5-HT-enhanced accumulation of [32P]-cyclic AMP was unaffected by the 5-HT4 antagonist RS39604 (0.1 μM) or the 5-ht6 antagonist Ro 04-6790 (1 μM) but significantly attenuated by mesulergine (250 nM), ritanserin (450 nM) or methiothepin (200 nM) which have high affinity for the 5-HT7 receptor.Intracerebroventricular pretreatment with the serotonergic neurotoxin 5,7-dihydroxytryptamine, 5,7-DHT, elevated the [3H]-5-HT Bmax 2 fold, indicating that the hypothalamic 5-HT7 receptor is post-synaptic to 5-HT nerve terminals and regulated by synaptic 5-HT levels.These results suggest that, in the presence of 3 μM pindolol, [3H]-5-HT selectively labels hypothalamic binding sites consistent with functional 5-HT7 receptors.
机译:class =“ enumerated” style =“ list-style-type:decimal”> <!-list-behavior =枚举前缀-word = mark-type = decimal max-label-size = 0-> 品纳洛尔不敏感的[ 3 H] -5-羟基色胺([ 3 H] -5-HT)与大鼠下丘脑膜的结合在药理和功能上得以表征,以解决该程序选择性标记5-HT7受体。 与以前的报道一致,要完全占据5-HT1A和5-HT1B受体,需要3μm而非100μnM的吲哚洛尔。剩下的[ 3 H] -5-HT结合是饱和的(KD,1.59±0.21 nM; Bmax,53.8±3.1 fmol.mg蛋白 -1 )。 用美特古琳和5-CT置换[ 3 H] -5-HT表现出较浅的希尔斜率(<0.5),但其他七个化合物的斜率均大于0.8,pKi值和等级顺序的亲和力与已发表的[ 3 H] -5-HT与大鼠重组5-HT7受体的结合密切相关(分别为r = 0.81和0.93)。 吲哚洛尔对5-HT4拮抗剂RS39604(0.1μM)或5-ht6拮抗剂Ro 04-6790(1μM)的影响[ 32 P]-环AMP的5-HT增强堆积),但被对5-HT7受体具有高度亲和力的美舒麦碱(250 nM),利坦色林(450 nM)或甲硫基噻吩(200 nM)显着减弱。 5,7-DHT二羟基色胺使[ 3 H] -5-HT Bmax升高2倍,表明下丘脑5-HT7受体 这些结果表明,在存在3μM的潘多洛尔的情况下,[ 3 H ] -5-HT选择性标记与功能性5-HT7受体一致的下丘脑结合位点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号